Erick DeVinney
Vermögen: 11 Mio $ am 30.06.2026
Vermögen: 11 Mio $ am 30.06.2026
Mr. Erick W.
DeVinney is a Chief Innovation Officer at Axogen, Inc. He is on the Board of Directors at Global Nerve Foundation.
Mr. DeVinney was previously employed as a Director-Clinical & Translational Sciences by Axogen Corp., a Manager-Clinical Operations by Angiotech Pharmaceuticals, Inc., a Principal by Medical College of Virginia, and a Principal by National Clinical Research Centers, Inc. He received his undergraduate degree from Virginia Commonwealth University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AXOGEN, INC. 0,45 % | 01.04.2026 | 237 781 ( 0,45 % ) | 11 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AXOGEN, INC. | Corporate Officer/Principal | 04.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Develops peripheral nerve grafting and regeneration technologies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical trials management; pharmaceutical | Corporate Officer/Principal | - |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical trials management; pharmaceutical | Commercial Services |
Virginia Commonwealth University
Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Develops peripheral nerve grafting and regeneration technologies | Health Technology |
Axogen, Inc.
Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen